okogen / Home -

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://okogen.com/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	Home -
Description	Developing Innovative Therapeutics for Ocular Home About Research & Development Adenoviral Conjunctivitis Clinical Trials News & Press Contact Us Menu Home About Research & Development Adenoviral Conj
Keywords	N/A

Server Information

WebSite	okogen.com
Host IP	141.193.213.10
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

okogen.com Valuation

US$2,006,180

Last updated: 2023-05-18 16:09:38

okogen.com has Semrush global rank of 5,275,850. okogen.com has an estimated worth of US$ 2,006,180, based on its estimated Ads revenue. okogen.com receives approximately 231,483 unique visitors each day. Its web server is located in United States, with IP address 141.193.213.10. According to SiteAdvisor, okogen.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,006,180
Daily Ads Revenue	US$1,852
Monthly Ads Revenue	US$55,556
Yearly Ads Revenue	US$666,669
Daily Unique Visitors	15,433
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
okogen.com.	A	300	IP: 141.193.213.10
okogen.com.	A	300	IP: 141.193.213.11
okogen.com.	NS	86400	NS Record: emma.ns.cloudflare.com.
okogen.com.	NS	86400	NS Record: dan.ns.cloudflare.com.
okogen.com.	MX	300	MX Record: 10 alt3.aspmx.l.google.com.
okogen.com.	MX	300	MX Record: 5 alt2.aspmx.l.google.com.
okogen.com.	MX	300	MX Record: 5 alt1.aspmx.l.google.com.
okogen.com.	MX	300	MX Record: 1 aspmx.l.google.com.
okogen.com.	MX	300	MX Record: 10 alt4.aspmx.l.google.com.
okogen.com.	TXT	300	TXT Record: google-site-verification=hT1zxOZaQBxevwMGIvMLNuBjdMuYLOK6_cyXI1piN7I

HtmlToTextCheckTime:2023-05-18 16:09:38

Home About Research & Development Adenoviral Conjunctivitis Clinical Trials News & Press Contact Us Menu Home About Research & Development Adenoviral Conjunctivitis Clinical Trials News & Press Contact Us Developing Innovative Therapeutics for Ocular Diseases Global leading candidate in Phase 2b for the treatment of adenoviral conjunctivitis. Research & Development Enhancing Lives Through Better Vision Okogen, founded in 2015, is a clinical stage ophthalmic specialty biotechnology company. We are exclusively focused on developing the leading treatment of adenoviral conjunctivitis. With acute conjunctivitis representing 1% of all primary care visits in the US, we see a significant need and opportunity. Up to 3 million new cases of adenoviral conjunctivitis per year in the US. Acute conjunctivitis accounts for 35% to 50% of all eye diseases examined by general practitioners. There are currently no approved therapeutics available to treat adenoviral conjunctivitis today. Meet the Team

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 02 Jul 2022 08:52:18 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://okogen.com/
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=KuRZFDHik1GeyAIUVdhKUBmKOrLrGQQ3CuBvtxej6oRsaCIjthjmpicyyq%2Bg2lhvOaCwgkEsL9pUzKENy6sxTkFfCiV2zpJu8hbiEXQIFb4ux%2FF5Rp%2FiiBecSU0%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 724624ff0c953a89-DME
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

HTTP/2 200 
date: Sat, 02 Jul 2022 08:52:19 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
vary: Accept-Encoding,Cookie
x-powered-by: WP Engine
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-cacheable: SHORT
cache-control: max-age=600, must-revalidate
x-cache: HIT: 2
x-cache-group: normal
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=6F8ECx%2BbU17WxiIvb%2B2NFd8CmVk3Pdp8JOnEvUJmiRMTp%2Bqbm%2F4y%2Ffd9RfT9jznKFD7%2B8Mj%2BMAAztVWtXOLmcBO0EmT1r6aGne6Xr9Kzp56pPJxd5433fFUEv7Y%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 724625028c607a69-DME
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400

okogen.com Whois Information

Domain Name: OKOGEN.COM
Registry Domain ID: 1931059762_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.directnic.com
Registrar URL: http://www.directnic.com
Updated Date: 2022-05-24T18:08:20Z
Creation Date: 2015-05-21T16:31:45Z
Registry Expiry Date: 2023-05-21T16:31:45Z
Registrar: DNC Holdings, Inc.
Registrar IANA ID: 291
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: DAN.NS.CLOUDFLARE.COM
Name Server: EMMA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-07-02T08:55:23Z <<<

okogen.com valuation and analysis